CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Float-adjusted market cap methodology weights constituents by market value adjusted for free float. This approach influences index composition and risk exposure.
27,567 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
A new Fed chair angles for a disciplined inflation fight and a leaner balance sheet, even as markets seek clarity. He...
Broadcom inks a long-term extension with Apple through 2031, tying roughly 20% of AVGO's annual sales to the iPhone m...
Tesla stands out as a founder led tech titan in a sea of transitions. This guide explains why elon musk's tesla remai...
Bitcoin trades within a broad range as traders watch a historic buy zone. ETF-driven liquidity and macro shifts could...
A prominent investment firm stepped into Black Hills Corporation, driving a 22% gain over the year. This article brea...
Investors are asking if costco stock going $1,500? is possible. This guide breaks down what would have to happen, the...
Even a $1 million nest egg isn’t a guaranteed shield. With rising health costs, longer lifespans, and market swings, ...
Major banks reduced their Figma price targets even as the company posted rapid revenue growth, signaling that AI comp...
March data from the Case-Shiller indices confirms a slower pace of home price growth, signaling ongoing cooling acros...
As private markets steal the spotlight, Brookfield Asset Management and Ares Management stand out. This in-depth, ori...
Cerebras' first earnings report brings a clear message for AI stock shoppers: growth alone isn't enough. Here's how t...